REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,232,358 | +32.1% | 32,439 | -12.6% | 0.18% | +43.7% |
| Q3 2022 | $933,000 | +14.9% | 37,108 | +38.9% | 0.13% | +18.9% |
| Q2 2022 | $812,000 | +89.3% | 26,708 | +104.1% | 0.11% | +107.8% |
| Q1 2022 | $429,000 | -27.8% | 13,087 | +121.5% | 0.05% | -8.9% |
| Q3 2021 | $594,000 | -30.2% | 5,909 | -1.7% | 0.06% | -23.3% |
| Q2 2021 | $851,000 | -8.0% | 6,012 | -77.3% | 0.07% | -24.7% |
| Q2 2018 | $925,000 | -49.1% | 26,439 | -70.2% | 0.10% | -57.1% |
| Q1 2018 | $1,819,000 | -6.8% | 88,675 | +28.7% | 0.23% | +13.0% |
| Q4 2017 | $1,951,000 | +3.8% | 68,906 | +14.0% | 0.20% | -23.4% |
| Q3 2017 | $1,880,000 | – | 60,464 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |